Vivus has promoted its COO, Peter Tam, to president. Tam has held various leadership positions at Vivus over the last 16 years, including director of clinical and corporate development, senior vice president of product and corporate development and chief operating officer. Vivus release
Rosetta Genomics announced the appointment of Kenneth A. Berlin to the position of president and CEO. Release
Mara Aspinall, a former senior executive at Genzyme, is taking the helm of On-Q-ity, a new cancer diagnostics business. Story
NeoPharm announced the appointment of Dr. Aquilur Rahman to the position of president and CEO. NeoPharm release
Codexis has named Robert Lawson as senior vice president and chief financial officer. Read Codexis release
Medicure announced the appointment of Eric Johnstone as chief financial officer. Check out Medicure release
Watson Pharmaceuticals named Todd Joyce as senior vice president and chief financial officer, succeeding Mark Durand, who left for personal reasons. Story
Alnara Pharmaceuticals announced the appointment of Lee R. Brettman, M.D., FACP, to the newly created position of chief medical officer. Read the Alnara release
Chelsea Therapeutics named Dr. William Schwieterman to the newly created position of chief medical officer. Report
Ferring Pharmaceuticals has named Harry F. Kovelman, MD as associate medical director for Orthopaedics. Release
Emergent Technologies announced that David Sougstad has been hired as the new executive director of the Abilene Life Sciences Accelerator. Release
SV Life Sciences announced the appointment of two new venture partners, Patrick T. Ryan and James C. Wachtman, both of whom will be based in the firm`s Boston office. Release
David Kennedy has joined Girindus as director of operations. Release
Laureate Pharma added three new members to its business development team. Andrew Arrage joins Laureate as Director, Business Development - East; Patricia Caplan joins Laureate as Director, Business Development - East; and Bruce Frazier joins Laureate as Manager, Business Development - West. Release
INC Research named Wayne Whittingham as vice president, regulatory affairs and strategic drug development. Release
The Board
Affymax named Hollings C. Renton - the former chairman of Onyx--to the position of chairman of the board, replacing Nick Galakatos, who served as lead board member since the company`s initial public offering in 2006 and who will be resigning his position as a member of the board of directors at the end of 2009. Release
Amicus Therapeutics has named Margaret G. McGlynn, R.Ph., to its board of directors. McGlynn most recently served as president of vaccines and infectious diseases for Merck. Release
Fresenius Kabi Pharmaceuticals Holding, which acquired APP Pharmaceuticals on September 10, 2008, announced the election of Bernhard Hampl, Ph.D. to its board of directors. Release
David Stout, once a contender for the helm at GlaxoSmithKline, has been named a director at Shire. Story
Quintiles Executive Vice President and Chief Information Officer William "Bill" Deam has been named to the "CIO Hall of Fame." Release